Neurology and Neurosurgery

91-105 of 108

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  MinuteCE®

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credits

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 credits 10 episodes

• 

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  MinuteCE®

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credits
• advertisement

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  MinuteCE®

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  MinuteCE®

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  MinuteCE®

  Decoding CIDP: Exploring Common and Atypical Variants

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Duchenne Muscular Dystrophy: Differentiating Advances in Treatment 

  CME/CE

  Duchenne Muscular Dystrophy: Differentiating Advances in Treatment 

  • 

    

    Omer Abdul Hamid, MD

  • 

    

    Nancy Kuntz, MD

  • 

    

    Migvis Monduy, MD

  0.25 credits
• advertisement

• 

  RestartResume

  5 Things You Need to Know About Epilepsy & Depression

  CME/CE

  5 Things You Need to Know About Epilepsy & Depression

  • 

    

    Heidi M. Munger Clary, MD, MPH

  • 

    

    Jay Salpekar, MD, FANPA

  0.25 credits

• 

  RestartResume

  Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome

  CME/CE

  Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome

  • 

    

    Nilika Singhal, MD

  • 

    

    M. Scott Perry, MD

  • 

    

    Elizabeth Anne Thiele, MD, PhD

• 

  RestartResume

  Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes

  CME/CE

  Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes

  • 

    

    Danielle Becker, MD, MS, FAES

  • 

    

    Ahmed Abdelmoity, MD

  • 

    

    Deborah Holder, MD

  • 

    

    John Stern, MD

• Prev
• 1
• 2
• …
• 5
• 6
• 7
• 8
• Next